Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 · kind B2 · utility
18Cited by
570References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 2016 |
| Grant date | Feb 25, 2020 |
| Priority date | — |
| Expiry date | Dec 7, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.